check_circleStudy Completed

Rhinitis, Allergic

Bayer Identifier:

21614

ClinicalTrials.gov Identifier:

NCT04645979

EudraCT Number:

Not Available

EU CT Number:

Not Available
A study to learn what participants think of treatment with betamethasone plus loratadine to treat their acute allergic rhinitis, also known as hay fever in Mexico

Trial purpose

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Key Participants Requirements

Sex

All

Age

20 - 50 Years
  • - Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis
    - Participants allowing to use the data for research and marketing purposes as well as talking to authorities
    - Participants allowing us to use the pseudo-randomized individual data for further data analysis
    - Able to read and understand the language of the online questionnaire
  • - None

Trial summary

Enrollment Goal
153
Trial Dates
November 2020 - November 2020
Phase
N/A
Could I Receive a placebo
No
Products
Betamethasone/Loratadine (BAY987498)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many locationsMany locations, Mexico

Primary Outcome

  • Experience with betamethasone plus loratadine via an online questionnaire
    Participants' experiences with betamethasone plus loratadine used under real life conditions.
    date_rangeTime Frame:
    2 months

Trial design

The perception of Celestamine treatment in Mexico: a retrospective assessment of consumer perception of prior Celestamine use
Trial Type
Observational
Intervention Type
Other
Trial Purpose
Treatment
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here to find results for studies related to Bayer products